Tenderwize
Retour à la recherche

Open-house rebate agreement for Buserelin

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Dec 05, 2026 · 98 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Buserelin, ATC L02AE01

46/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

46 / 100

Complexité

58 / 100

Facteurs de risque

The buyer explicitly states this is an open-house model and not a standard competitive procurement procedure, so usual...

Submission format is strict: either handwritten paper originals in duplicate or electronic submission with a qualified...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jan 2027
  • Non-exclusive open-house rebate agreements for the active substance Buserelin (ATC L02AE01).
  • Supply of pharmaceutical products under a pre-defined contract model.
Afficher le résumé complet

This is an open-house pharmaceutical supply arrangement for Buserelin (ATC L02AE01) offered by AOK Bayern. It is not a competitive award procedure in the usual sense: the buyer states that no selection among bidders is made and that any pharmaceutical company meeting the stated eligibility conditions may join on identical, non-negotiable terms. The contract term runs from 2025-02-01 to 2027-01-31, with contract entry possible until 2026-12-05. Submission is allowed electronically with a qualified electronic signature or in paper form; documents not in German must be submitted with a German translation. Procurement documents are available via DTVP, but only the notice text was analyzed, not the full document set.

Risques

The buyer explicitly states this is an open-house model and not a standard competitive procurement procedure, so usual...

Submission format is strict: either handwritten paper originals in duplicate or electronic submission with a qualified...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • If the signatory is not authorized in the commercial register, a power of attorney must be provided.

Administrative

  • Submit a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Submit the completed and signed contract and the completed and signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Buserelin

Single lot covering non-exclusive open-house rebate agreements for the medicinal product Buserelin, ATC L02AE01. The scope is pharmaceutical products/supplies in Germany, with performance in Bavaria (DE212). The notice says the contract terms are pre-set and not individually negotiable.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Jan 2025 - Jan 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Dec 05, 2026

Détails de la procédure

Date de publication
15 Dec 2024
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
768779-2024

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30